Cognet-X, Inc.: Managed Care Executives Rank Wyeth Best for Pull-through Programs.Business Editors/Health/Medical Writers FEASTERVILLE, Pa.--(BUSINESS WIRE)--May 20, 2003 In the first-quarter 2003, Wyeth ranked first with leading managed care pharmacy pharmacy, art of compounding and dispensing drugs and medication. The term is also applied to an establishment used for such purposes. Until modern times medication was prepared and dispensed by the physician himself. In the 18th cent. directors for offering the best pull-through pull-through a surgical technique for abdominoperineal resection of the rectum. After removal of a segment, the rectum is sutured to the perineal skin, forming a new mucocutaneous junction. Used in the treatment of rectal neoplasms and anal furunculosis. programs, Cognet-X, Inc. reported today. This marked the third consecutive time that Wyeth placed first in the Pull-through Programs category, one of several Corporate Assessment categories in Cognet-X's PAR-Rx (Promotional Assessment Research) Report(TM). Points are accrued ac·crue v. ac·crued, ac·cru·ing, ac·crues v.intr. 1. To come to one as a gain, addition, or increment: interest accruing in my savings account. 2. through Cognet-X's proprietary Scale of Influence model. Cognet-X PAR-Rx panelists participate in Corporate Assessment rankings twice each year. Pull-through programs are pharmaceutical company initiatives designed to increase the market share of specific products while reducing pharmaceutical expenditures for managed care organizations. In addition to Wyeth's first-place ranking, another trend continued in the first quarter Pull-through Programs assessment. Two other top-five companies in the Pull-through Programs category market proton pump inhibitors Proton Pump Inhibitors Definition The proton pump inhibitors are a group of drugs that reduce the secretion of gastric (stomach) acid. They act by binding with the enzyme H+, K(+)-ATPase, hydrogen/potassium adenosine triphosphatase . Wyeth markets Protonix. AstraZeneca manufactures Nexium (and the now off-patent Prilosec); AstraZeneca ranked second, up from third place in the 3Q 2002 ranking period. TAP Pharmaceuticals TAP Pharmaceuticals is an Japanese pharmaceutical company. It is a joint venture between Abbott Laboratories and the Japanese Takeda Pharmaceutical Company, formed in 1977. , Inc. retained its fourth-place ranking; TAP promotes Prevacid. Novartis placed third; it had been ranked second in the previous assessment cycle. Sankyo Pharma, which was previously not ranked in this category, finished fifth in the 1Q 2003 cycle. Three other companies climbed into the top 10 rankings in the first-quarter assessment period. Joining the top 10 firms in the Pull-through Programs category were: Hoffmann-La Roche, Inc. (eighth, up from 17th); Novo Nordisk Wikipedia is not the place for advertisement or self-advertising. Novo Nordisk (, NYSE: NVO) manufactures and markets pharmaceutical products and services. Founded in Denmark in 1923, the company has since become a world leader in diabetes care with the broadest Pharmaceuticals (ninth, up from 12th); and Takeda (tied for ninth, up from 16th). Merck & Co., Inc. and Pharmacia Corp. (pre-merger with Pfizer, Inc.) tied for sixth place in the 1Q 2003 period, followed by Abbott Laboratories Abbott Laboratories (NYSE: ABT) is a diversified pharmaceuticals and health care company. It has over 65,000 employees and operates in 130 countries. The corporate headquarters are in Abbott Park, Illinois, a neighborhood of North Chicago, Illinois. in seventh place. Aventis Pharma AG, which had ranked sixth in the 3Q 2002 period, ranked 10th in the most recent Pull-through Programs assessment. About the PAR-Rx Report Cognet-X's PAR-Rx Report is a year-round service that provides the pharmaceutical industry with real-time, Internet-based competitive intelligence on pharmaceutical company promotion to influential managed care pharmacy directors. The Report offers Cognet-X clients the ability to evaluate and analyze variable differences that are critically important to their decision-making process. The Report collects comprehensive data that can be segmented and analyzed an·a·lyze tr.v. an·a·lyzed, an·a·lyz·ing, an·a·lyz·es 1. To examine methodically by separating into parts and studying their interrelations. 2. Chemistry To make a chemical analysis of. 3. to provide clients with "21st-Century solutions to their 21st-Century challenges." About Cognet-X Cognet-X offers the pharmaceutical industry market research, consulting and software development that help companies build and refine their relationships with numerous customer bases, including the managed care community. Based in Bucks County, Pennsylvania Bucks County is a county located in the U.S. state of Pennsylvania. As of 2000, the population was 597,635. A 2004 U.S. Census estimate placed the population at 621,342, making it the fourth most populous county in Pennsylvania, after Philadelphia, Allegheny, and Montgomery , Cognet-X is privately held and employee-owned. For more information on the PAR-Rx Report or other valuable Cognet-X products, please contact Robert E. Houghton (extension 101) or James A. Barone (extension 102) at 215/396-8300 or via e-mail at robh@cognetx.com or jimb@cognetx.com. |
|
||||||||||||
Printer friendly
Cite/link
Email
Feedback
Reader Opinion